Acne

An expert discusses which types of products tend to be more comdedogenic and acnegenic.

An expert discusses available types of facial foundations and their effect on the skin in regards to acne.

Pediatric atopic dermatitis and acne have some similarities when these present in skin of color and lighter-skin children. But there are important differences when these common skin conditions affect darker skin types. An expert discusses how treatments should be approached.

Dividing the pediatric population into three age groups helps streamline effective treatment for acne.

Evidence is mounting for the use of probiotics, prebiotics and microbial lysates in skincare. One expert examines the literature and shares observations.

Facial care advice for patients with acneWhile both benzoyl peroxide acne preparations and vitamin C products carry benefits in acne treatment, it’s wise to recall the characteristics of each element in advising patients on caring for their skin. Vitamin C is rapidly oxidized with exposure to air. Benzoyl peroxide is an oxidant. This is how Dr. Draelos suggests these products be used.

Data suggest photodynamic therapy with the investigational topical methyl aminolevulinate may be an effective treatment for patients with severe facial acne.

Results from three phase 3 trials, suggest ixekizumab (Talz, Eli Lilly & Company) is effective through 60 weeks of treatment among patients with moderate-to-severe plaque psoriasis.

The acne app offers a free and immediate analysis of acne type and severity; develops an individualized acne control plan; and monitors users’ progress. It aims to help consumers diagnose, treat, manage and prevent acne.

Researchers report on survey findings that shed light on why patients find acne consultations ineffective.

Researchers reveal that patients may have concerns with acne consultations. The authors offer tips to improve acne consults.

Acne presents with certain nuances in darker skin patients. Exacerbating factors, treatment approaches and desired treatment outcomes may differ from lighter skin patients.

The investigational sebum-inhibiting topical DRM01 had positive results in a phase 2b study, which paves the way for phase 3 trials planned for 2017.

GlobalMed has represented medical and aesthetic dermatology brands, including BMT, CoolTouch and Radiancy, since 1996. Omnilux noninvasively treats dermatologic conditions, including acne, fine lines and wrinkles and non-melanoma skin cancer.

A growing number of studies suggest diet influences general skin health and specific skin diseases, from acne and eczema to skin aging. Dermatologists share their best practices for using diet to combat skin disease and promote skin health.

Two novel energy-based approaches are ushering in a new era in acne treatment. One expert addresses the role these devices may play.

While oral isotretinoin has been associated with various side effects and routine blood tests have been recommended, evidence points to inconsistencies in monitoring practices. Many physicians also are questioning whether the effort has value.

Experts discuss association between inflammasomes and acne that may lead to treatments stopping acne before clinical signs emerge.

While many are in early phase studies, most of the new topical options are targeting sebum reduction, a novel pathway to controlling acne, and the data are exciting, one expert says.

New findings support dietary and supplementation practices that can influence acne. One expert discusses modifications in context of protocols for managing the condition.

The AAD’s new guidelines for the care and management of acne vulgaris include several updates for dermatologists, including an increased emphasis on oral antibiotic stewardship and recommendations for use.

Allergan announced in late February that the FDA approved its topical Aczone (dapsone) Gel, 7.5% for treatment of acne vulgaris.

Research shows dermatologists are overprescribing antibiotics for acne treatment, and patients and their parents seem unaware of the consequences, as well as alternatives to antibiotic treatment for acne.

Patients expect dermatologists to have answers for which cosmeceuticals can help their condition. Experts run through pros and cons of several common ingredients.

Study demonstrates current antibiotic use for acne therapy far surpasses guideline recommendations and calls for dermatologists to decrease extended courses of antibiotics through early recognition of failure and guiding patients to alternative therapies.

Evidence from recently published papers provides insight to address some common questions pertaining to the safe use of certain acne medications. Learn more

There is an absence of strong evidence supporting the recommendation that cumulative dosing of isotretinoin follow a reference range of 120 to 150 mg/kg. This points to the need for clinicians to treat their patients to achieve clearance of acne rather than adhere to this range.

Clinicians recognize that acne is increasingly presenting in pre-adolescents and that early presentation is also a predictor of worse disease in the future and the potential for scarring. Prompt, aggressive treatment will lead to better outcomes and will reduce the potential for adverse psychosocial effects.

The stories of the heroes behind these and other dermatologic therapeutic discoveries are recounted in the book To Heal the Skin: The Heroes Behind Discoveries in Dermatology edited by the late Stuart Maddin, M.D., F.R.C.P.C., professor emeritus at the University of British Columbia (UBC) in Vancouver, Canada, and a leader and pioneer in dermatology in Canada and internationally, and Eileen Murray, M.D., F.R.C.P.C., a dermatologist and adjunct professor at UBC. Learn more

Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. In this final segment, the two discuss whether a waiting period is necessary before treating acne scars and the questionable existence of pityrosporum folliculitis.